Work

Pharmacokinetic study of the phase III, randomized, double-blind, multicenter trial (TRIBUTE) of paclitaxel and carboplatin combined with erlotinib or placebo in patients with advanced Non-small Cell Lung Cancer (NSCLC)

Year: 2010

Type: article

Source: Investigational New Drugs

DOI: 10.1007/s10637-009-9380-z

Authors: Hai T. Tran, Ralph G. Zinner, George R. Blumenschein, Yun W. Oh, Vassiliki A. Papadimitrakopoulou, Edward S. Kim, Charles Lu, Mubashira Malik, Bert L. Lum, Roy S. Herbst

Institutions: The University of Texas MD Anderson Cancer Center, Georgetown University, Genentech

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2171634902

FWCI: 1.849

Cites: 13

Cited by: 19

Related to: 10